BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)

NCT00605215 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1331

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Laquinimod
DRUG: Placebo
DRUG: Avonex®

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.